Reexamination of the relationship between the prevalence of hepatitis C virus and parenteral antischistosomal therapy among Egyptians resident in Qatar

Clinical and Experimental Gastroenterology

Volumn 7, Issue , 2014, Pages 427-433

  Derbala, Moutaz ^a,b   Chandra, Prem ^c   Amer, Aliaa ^a   John, Anil ^a   Sharma, Manik ^a   Amin, Ashraf ^a   Thandassery, Ragesh Babu ^a   Faris, Amr ^a  

^a HAMAD GENERAL HOSPITAL   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^c HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Epidemiology; HCV; Schistosomiasis

Indexed keywords

PRAZIQUANTEL; VIRUS RNA;

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG THERAPY; EGYPTIAN; GENETIC PREDISPOSITION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 1A; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PARENTERAL ANTISCHISTOSOMAL THERAPY; PATIENT HISTORY OF THERAPY; PERSISTENT INFECTION; PREVALENCE; QATAR; RISK ASSESSMENT; RISK FACTOR; RURAL POPULATION; SCHISTOSOMIASIS; SEROEPIDEMIOLOGY; SOCIAL STATUS; VIRUS EXAMINATION; VIRUS TRANSMISSION;

EID: 84908507211     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S65369     Document Type: Article

References (48)

1. Williams R. Global challenges in liver disease. Hepatology. 2006; 44(3): 521-526.
2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-1342.
3. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A. 2010; 107(33): 14757-14762.
4. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000; 355(9207): 887-891.
5. Arafa N, El Hoseiny M, Rekacewicz C, et al. Changing patterns of hepatitis C virus spread in rural areas of Egypt. J Hepatol. 2005; 43(3): 418-424.
6. Mostafa A, Taylor SM, el-Daly M, et al. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int. 2010; 30(4): 560-566.
7. Saleh DA, Shebl F, Abdel-Hamid M, et al. Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. Trans R Soc Trop Med Hyg. 2008; 102(9): 921-928.
8. Shebl FM, El-Kamary SS, Saleh DA, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol. 2009; 81(6): 1024-1031.
9. Plancoulaine S, Mohamed MK, Arafa N, et al. Familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut. 2008; 57(9): 1268-1274.
10. Hussein E, Teruya J. Evaluation of blood supply operation and infectious disease markers in blood donors during the Egyptian revolution. Transfusion. 2012; 52(11): 2321-2328.
11. Bakr I, Rekacewicz C, El Hosseiny M, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006; 55(8): 1183-1187.
12. Daniel HD, Abraham P, Raghuraman S, Vivekanandan P, Subramaniam T, Sridharan G. Evaluation of a rapid assay as an alternative to conventional enzyme immunoassays for detection of hepatitis C virus-specific antibodies. J Clin Microbiol. 2005; 43(4): 1977-1978.
13. Guerra J, Garenne M, Mohamed MK, Fontanet A. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat. 2012; 19(8): 560-567.
14. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis. 2013; 13: 288.
15. El-Sadawy M, Ragab H, el-Toukhy H, et al. Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. J Egypt Soc Parasitol. 2004; 34(Suppl 1): 367-384.
16. Indolfi G, Azzari C, Resti M. Perinatal transmission of hepatitis C virus. J Pediatr. 2013; 163(6): 1549-1552. e1.
17. Medhat A, Shehata M, Magder LS, et al. Hepatitis C in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg. 2002; 66(5): 633-638.
18. Al-Rabeei NA, Al-Thaifani AA, Dallak AM. Knowledge, attitudes and practices of barbers regarding hepatitis B and C viral infection in Sana'a city, Yemen. J Community Health. 2012; 37(5): 935-939.
19. Goldberg E, Shopra S, O'Donovan D. Vertical transmission of hepatitis C virus. 2014. Available from: http://www. uptodate. com/contents/vertical-transmission-of-hepatitis-c-virus. Accessed August 18, 2014.
20. Shebl FM, El-Kamary SS, Saleh DA, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol. 2009; 81(6): 1024-1031.
21. El-Kamary SS, Hashem M, Saleh DA, et al. Hepatitis C virus-specific cell-mediated immune responses in children born to mothers infected with hepatitis C virus. J Pediatr. 2013; 162(1): 148-154.
22. AbdulQawi K, Youssef A, Metwally MA, Ragih I, AbdulHamid M, Shaheen A. Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants. Croat Med J. 2010; 51(3): 219-228.
23. Pfaender S, Heyden J, Friesland M, et al. Inactivation of hepatitis C virus infectivity by human breast milk. J Infect Dis. 2013; 208(12): 1943-1952.
24. Magder LS, Fix AD, Mikhail NN, et al. Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. Int J Epidemiol. 2005; 34(1): 160-165.
25. Vandelli C, Renzo F, Romanò L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol. 2004; 99(5): 855-859.
26. Tahan V, Karaca C, Yildirim B, et al. Sexual transmission of HCV between spouses. Am J Gastroenterol. 2005; 100(4): 821-824.
27. Terrault NA, Dodge JL, Murphy EL, et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013; 57(3): 881-889.
28. Paez Jimenez A, Sharaf Eldin N, Rimlinger F, et al. HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut. 2010; 59(11): 1554-1560.
29. Stoszek SK, Abdel-Hamid M, Narooz S, et al. Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Trans R Soc Trop Med Hyg. 2006; 100(2): 102-107.
30. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatitis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol. 2006; 12(43): 7025-7028.
31. Habib M, Mohamed MK, Abdel-Aziz F, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology. 2001; 33(1): 248-253.
32. Awadalla HI, Ragab MH, Nassar NA, Osman MA. Risk factors of hepatitis C infection among Egyptian blood donors. Cent Eur J Public Health. 2011; 19(4): 217-221.
33. Perumalswami PV, Miller FD, Orabee H, et al. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community. Liver Int. 2014; 34(2): 253-258.
34. Murad EA, Babiker SM, Gasim GI, Rayis DA, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana'a, Yemen. BMC Pregnancy Childbirth. 2013; 13: 127.
35. Chemaitelly H, Abu-Raddad LJ, Miller FD. An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt. PLoS One. 2013; 8(7): e69803.
36. Paez Jimenez A, Mohamed MK, Eldin NS, et al. Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One. 2009; 4(9): e7193.
37. Guerra J, Garenne M, Mohamed MK, Fontanet A. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat. 2012; 19(8): 560-567.
38. Pépin J, Lavoie M, Pybus OG, et al. Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis. 2010; 51(7): 768-776.
39. Mullis CE, Laeyendecker O, Reynolds SJ, et al. High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clin Infect Dis. 2013; 57(12): 1747-1750.
40. Mudawi HM, Smith HM, Fletcher IA, Fedail SS. Prevalence and common genotypes of HCV infection in Sudanese patients with hepatosplenic schistosomiasis. J Med Virol. 2007; 79(9): 1322-1324.
41. Gasim GI, Hamdan HZ, Hamdan SZ, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. J Med Virol. 2012; 84(1): 52-55.
42. Laouénan C, Plancoulaine S, Mohamed MK, et al. Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions. Hum Genet. 2009; 126(5): 697-705.
43. Zekri AR, El-Mahallawy HA, Hassan A, El-Din NH, Kamel AM. HLA alleles in Egyptian HCV genotype-4 carriers. Egypt J Immunol. 2005; 12(1): 77-86.
44. Mosaad YM, Farag RE, Arafa MM, et al. Association of human leucocyte antigen class I (HLA-A and HLA-B) with chronic hepatitis C virus infection in Egyptian patients. Scand J Immunol. 2010; 72(6): 548-553.
45. Grimaldi V, Sommese L, Picascia A, et al. Association between human leukocyte antigen class I and II alleles and hepatitis C virus infection in high-risk hemodialysis patients awaiting kidney transplantation. Hum Immunol. 2013; 74(12): 1629-1632.
46. Elsammak MY, Al-Sharkaweey RM, Ragab MS, Amin GM, Kandil MH. In Egyptians, a mutation in the lymphotoxin-alpha gene may increase susceptibility to hepatitis C virus but not that to schistosomal infection. Ann Trop Med Parasitol. 2008; 102(8): 709-716.
47. Tang S, Yue M, Wang J, Su J, et al. Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population. Eur J Clin Microbiol Infect Dis. 2014; 33(6): 999-1010.
48. Miki D, Ochi H, Takahashi A, et al. HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: A genome-wide association study. PLoS One. 2013; 8(12): e84226.